{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004233411282304.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/jhh.2013.68"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/jhh201368.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/jhh201368"}},{"identifier":{"@type":"PMID","@value":"24451269"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST Study at 16 weeks"}],"description":[{"notation":[{"@value":"Morning home blood pressure (BP) levels are more closely associated with cardiovascular risk than clinic BP levels. However, control of morning home BP has been worse than that of clinic BP in clinical practice. We examined the effects of olmesartan-based treatment using data (n=21 341) from the first 16 weeks of the Home BP measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) study, a prospective observational study for olmesartan-naive patients with essential hypertension. After 16-week olmesartan-based treatment, the clinic and morning home systolic BP (SBP) lowered from 151.6±16.4 and 153.6±19.0 mm Hg to 135.0±13.7 and 135.5±13.7 mm Hg, respectively (P0.0001). The achievement percentage of target morning home SBP (135 mm Hg) in all patients, those with diabetes mellitus (DM), and those with chronic kidney disease (CKD) increased from 13.5, 16.4 and 17.2% to 50.8, 47.9 and 48.8%, respectively, and the proportion of patients with well-controlled hypertension (clinic SBP140 mm Hg and morning home SBP135 mm Hg) increased from 7.9, 9.2 and 10.2% to 38.9, 34.5 and 36.3%, respectively. After 16-week olmesartan-based treatment, the proportion of patients with masked and white coat hypertension changed from 11.8 to 24.2% and 5.6 to 11.9%. In conclusion, both clinic and morning home BP in all, DM and CKD patients improved with 16-week olmesartan-based treatment in the 'real world', and the results showed a sustained 24-hour BP-lowering effect of olmesartan. Decrease in clinic and home BP resulted in an increased rate of masked and white coat hypertension, and further management is needed in those patients."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004233411282432","@type":"Researcher","foaf:name":[{"@value":"K Kario"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282440","@type":"Researcher","foaf:name":[{"@value":"I Saito"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282435","@type":"Researcher","foaf:name":[{"@value":"T Kushiro"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282565","@type":"Researcher","foaf:name":[{"@value":"S Teramukai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282451","@type":"Researcher","foaf:name":[{"@value":"Y Ishikawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282308","@type":"Researcher","foaf:name":[{"@value":"K Hiramatsu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282570","@type":"Researcher","foaf:name":[{"@value":"F Kobayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004233411282436","@type":"Researcher","foaf:name":[{"@value":"K Shimada"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09509240"},{"@type":"EISSN","@value":"14765527"}],"prism:publicationName":[{"@value":"Journal of Human Hypertension"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2013-07-18","prism:volume":"27","prism:number":"12","prism:startingPage":"721","prism:endingPage":"728"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/jhh201368.pdf"},{"@id":"http://www.nature.com/articles/jhh201368"}],"createdAt":"2013-07-18","modifiedAt":"2023-05-18","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Time%20Factors","dc:title":"Time Factors"},{"@id":"https://cir.nii.ac.jp/all?q=Imidazoles","dc:title":"Imidazoles"},{"@id":"https://cir.nii.ac.jp/all?q=Tetrazoles","dc:title":"Tetrazoles"},{"@id":"https://cir.nii.ac.jp/all?q=Blood%20Pressure","dc:title":"Blood Pressure"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Diabetes%20Complications","dc:title":"Diabetes Complications"},{"@id":"https://cir.nii.ac.jp/all?q=Heart%20Rate","dc:title":"Heart Rate"},{"@id":"https://cir.nii.ac.jp/all?q=Hypertension","dc:title":"Hypertension"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Original%20Article","dc:title":"Original Article"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Prospective%20Studies","dc:title":"Prospective Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Renal%20Insufficiency,%20Chronic","dc:title":"Renal Insufficiency, Chronic"},{"@id":"https://cir.nii.ac.jp/all?q=Angiotensin%20II%20Type%201%20Receptor%20Blockers","dc:title":"Angiotensin II Type 1 Receptor Blockers"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040282257050055296","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21390247"},{"@type":"JGN","@value":"JP21390247"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21390247/"}],"notation":[{"@language":"ja","@value":"夜間睡眠時トリガー血圧測定計の開発と臨床応用へ向けた国際多施設研究への展開"},{"@language":"en","@value":"Development of nocturnal triggered blood pressure monitor and international research for its clinical application"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011143768427264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144703864960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cardiovascular Prognosis of \"Masked Hypertension\" Detected by Blood Pressure Self-measurement in Elderly Treated Hypertensive Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146295937920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708382632576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709866909440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Morning blood pressure monitoring in the management of hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621013728896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184843826176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Detection of silent cerebrovascular lesions in individuals with ‘masked’ and ‘white-coat’ hypertension by home blood pressure measurement: the Ohasama study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360845539033188608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"HONEST to clarify association between home blood pressure and cardiovascular events under antihypertensive medication"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570564472704","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Morning Hypertension: The Strongest Independent Risk Factor for Stroke in Elderly Hypertensive Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045154141312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045528295424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519101892992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995490654336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468473592448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Circadian variation and triggers of onset of acute cardiovascular disease."}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943673074432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945052867584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945481158656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impact of Olmesartan on Progression of Coronary Atherosclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893341454848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Time for focus on morning hypertension: Pitfall of current antihypertensive medication"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894563823872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"2007 Guidelines for the Management of Arterial Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895510425856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895680459264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896122674304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369033061120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Is \"Isolated Home\" Hypertension as Opposed to \"Isolated Office\" Hypertension a Sign of Greater Cardiovascular Risk?"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843216683776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844233284096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845822408832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Home-Measured Blood Pressure Is a Stronger Predictor of Cardiovascular Risk Than Office Blood Pressure"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320077431808","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320408689408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Use of 24-Hour Ambulatory Blood Pressure Monitoring to Assess Antihypertensive Efficacy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794383304192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Early Antihypertensive Efficacy of Olmesartan Medoxomil"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794559077504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Importance of Home Blood Pressure Measurement for Preventing Stroke and Cardiovascular Disease in Hypertensive Patients: A Sub-Analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268499202048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268533745536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269092019840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Short- and Long-Term Incidence of Stroke in White-Coat Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269914470912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Status of Home Blood Pressure Measured in Morning and Evening: Evaluation in Normotensives and Hypertensives in Japanese Urban Population"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270195821568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil Assessed by 24-Hour Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842050436480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Preface : new CKD guidebook from the Japanese Society of Nephrology"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/jhh.2013.68"},{"@type":"KAKEN","@value":"PRODUCT-12720318"},{"@type":"OPENAIRE","@value":"doi_dedup___::224bfb2436b3dc3849409cdbb9ed005e"},{"@type":"CROSSREF","@value":"10.1097/hjh.0000000000001379_references_DOI_Hg3tG5BCwuhQb4AxgMS9cVxCbEt"},{"@type":"CROSSREF","@value":"10.1038/jhh.2013.151_references_DOI_Hg3tG5BCwuhQb4AxgMS9cVxCbEt"}]}